This biphasic feature of “low basal level-pathological compensatory increase” suggests that Musclin may play a different role in different stages of hypertension (such as vascular homeostasis vs. end organ injury), or be regulated by secondary factors such as inflammation and oxidative stress. This evidence concerns the gene OSTN and hypertensive disorder.